Skip to main content
Joseph Bellairs, MD, Otolaryngology (ENT), Federal Way, WA

JosephAndrewBellairsMD

Otolaryngology (ENT) Federal Way, WA

Head & Neck Plastic Surgery

Comprehensive otolaryngologist at Surgical Associates Northwest

Dr. Bellairs is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bellairs' full profile

Already have an account?

  • Office

    34612 6TH AVE S
    Federal Way, WA 98003

Summary

  • I am a board-eligible otolaryngologist specializing in comprehensive ear, nose, and throat (ENT) care. I completed my residency in Otolaryngology and Head and Neck Surgery at the University of Washington. I am dedicated to diagnosing and treating a wide range of ENT conditions in patients of all ages, from children to adults, ensuring that each patient receives personalized care tailored to their unique needs.

Education & Training

  • University of Washington
    University of WashingtonResidency, Otolaryngology - Head and Neck Surgery, 2017 - 2024
  • University of Washington
    University of WashingtonResidency, Otolaryngology - Head and Neck Surgery, 2024
  • University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
    University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2017

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2019 - 2026

Publications & Presentations

PubMed

Authored Content

  • Genomic Applications in Head and Neck CancerDecember 2018

Research History

  • Medical Student Research - University of ChicagoMentor: James L. LaBelle, MD, PhD “BIM BH3 peptide amphiphiles are potent inducers of cellular apoptosis.” - Generated novel peptide amphiphiles with BCL-2 family signaling peptides to modulate apoptosis and cell death pathways in malignant cancer cells2014 - 2017
  • Laboratory Research Technician - Dana FarberMentor: Loren D. Walensky, M.D., Ph.D. • Lead research efforts to characterize and further optimize BAM7, a small molecule activator of the proapoptotic BCL-2 family protein BAX. • Piloted In Vivo experiments to validate BAX Activator Molecules (BAMs) as novel therapeutic strategies2011 - 2013
  • Research Technician - Memorial Sloan KetteringMentor: Sean Carlin, Ph.D. · Investigated expression patterns of hypoxia regulated genes in cancer cell cultures using qRT-PCR · Optimized RNA extraction, reverse transcription step and SYBR-green based qPCR array techniques for hypoxia regulated genes2010 - 2010